Achieve Life Sciences ACHV Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $52.45M-4.4% | $54.88M+4.9% | $52.34M+4.4% | $50.11M+9.0% | $45.98M+17.7% | ||
| $908K+10.9% | $819K+7.1% | $765K-18.5% | $939K-39.5% | $1.55M-28.8% | ||
| $460K+98.3% | $232K+3,414% | -$7K+97.7% | -$304K-69.8% | -$179K+76.4% | ||
| —— | —— | —— | —— | —— | ||
| -$51.99M+4.9% | -$54.65M-4.4% | -$52.35M-3.8% | -$50.42M-9.2% | -$46.16M-15.9% | ||
| -$1.10+14.1% | -$1.28+7.2% | -$1.38+5.5% | -$1.46-9.0% | -$1.34-8.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is Achieve Life Sciences profitable?
- Achieve Life Sciences is not currently profitable: it reported a net loss of $52.0M over the trailing twelve months.
- What is Achieve Life Sciences's earnings per share?
- Achieve Life Sciences's diluted EPS over the trailing twelve months is $-1.10.
- Where does Achieve Life Sciences's income statement data come from?
- Every line is extracted from Achieve Life Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.